- Trials with a EudraCT protocol (413)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
413 result(s) found for: LH.
Displaying page 1 of 21.
EudraCT Number: 2022-003857-78 | Sponsor Protocol Number: D-CN-52014-244 | Start Date*: 2023-06-29 |
Sponsor Name:Ipsen Pharma | ||
Full Title: A phase III, open-label, multicentre, single arm study to assess the efficacy and safety of the triptorelin 6-month formulation in Chinese paediatric participants with central precocious puberty | ||
Medical condition: Central Precocious Puberty | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2019-004677-12 | Sponsor Protocol Number: RHYTHM | Start Date*: 2021-02-09 | |||||||||||
Sponsor Name:UNIVERSITA' DEGLI STUDI DI MODENA E REGGIO EMILIA - DIPARTIMENTO DI SCIENZE BIOMEDICHE, METABOLICHE E NEUROSCIENZE | |||||||||||||
Full Title: Pharmacodynamics and safety of human recombinant luteinising hormone in hypogonadotropic hypogonadal men. | |||||||||||||
Medical condition: Aquired hypogonadotropic hypogonadism | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001678-10 | Sponsor Protocol Number: 33 | Start Date*: 2007-09-14 | |||||||||||
Sponsor Name:HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON | |||||||||||||
Full Title: Suplementación con LH recombinante de la fase lútea previa a la estimulación ovárica con FSH recombinante para Fecundación ‘In Vitro’ en mujeres con edad avanzada. Estudio exploratorio para prueba ... | |||||||||||||
Medical condition: Sterility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002963-31 | Sponsor Protocol Number: D-CN-52014-243 | Start Date*: 2023-01-13 |
Sponsor Name:Ipsen Pharma | ||
Full Title: AN OPEN-LABEL, MULTICENTRE, SINGLE-ARM STUDY TO ASSESS THE EFFICACY AND SAFETY OF TRIPTORELIN 3-MONTH FORMULATION IN CHINESE CHILDREN WITH CENTRAL PRECOCIOUS PUBERTY | ||
Medical condition: Central Precocious Puberty | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2022-002471-11 | Sponsor Protocol Number: Leuprorelin-4002 | Start Date*: 2022-08-08 | |||||||||||
Sponsor Name:Takeda (China) International Trading Co., Ltd. | |||||||||||||
Full Title: An Open Label, Multicenter, Single-arm and Prospective Study to Assess the Efficacy and Safety of Leuprorelin 3M in the Treatment of Central Precocious Puberty (CPP) | |||||||||||||
Medical condition: Central Precocious Puberty | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001379-20 | Sponsor Protocol Number: 009 | Start Date*: 2018-05-23 | |||||||||||
Sponsor Name:Myovant Sciences GmbH | |||||||||||||
Full Title: A Phase 2a Randomized, Double-Blind, Placebo and Active Comparator-Controlled, Parallel Group, Dose-Range Finding Study of MVT-602 in Healthy Premenopausal Women Undergoing Controlled Ovarian Stimu... | |||||||||||||
Medical condition: Female infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005644-11 | Sponsor Protocol Number: 2-54-52014-143 | Start Date*: 2007-07-05 | |||||||||||
Sponsor Name:BEAUFOUR IPSEN PHARMA | |||||||||||||
Full Title: Phase III, multicentre, non comparative, open and single stage study to assess the efficacy and safety of pamoate of triptorelin 11.25 mg in children with precocious puberty | |||||||||||||
Medical condition: Precocious Puberty | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007115-87 | Sponsor Protocol Number: LH-HCGPES | Start Date*: 2008-02-08 |
Sponsor Name:FUNDACION CV INVESTIGACION HOSPITAL DR PESET | ||
Full Title: ENSAYO CLÍNICO UNICÉNTRICO PARA VALORAR LA EFICACIA DE LA ADMINISTRACIÓN EXÓGENA DE LH EN FORMA DE HCG EN EL TRATAMIENTO DE LA DISFUNCIÓN SEXUAL FEMENINA POR DISMINUCIÓN DEL DESEO SEXUAL | ||
Medical condition: DISMINUCIÓN DEL DESEO SEXUAL FEMENINO EN MUJERES MENOPÁUSICAS | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004494-16 | Sponsor Protocol Number: L-CP07-177 | Start Date*: 2014-12-03 | |||||||||||
Sponsor Name:Abbvie previously known as Abbott | |||||||||||||
Full Title: A 36 Month, Multi-Center, Open-Label Extension Study to Evaluate the Safety of Leuprolide Acetate 11.25 mg and 30 mg Formulations in Children with Central Precocious Puberty | |||||||||||||
Medical condition: Central Precocious Puberty | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006925-26 | Sponsor Protocol Number: no sponsor | Start Date*: 2007-04-05 |
Sponsor Name:Rijnstate hospital | ||
Full Title: Optimalising the Androgen-Oestrogen Balance in Testosterone Substituted Hypogonadal Men by Aromatase Inhibition. | ||
Medical condition: Men with hypogonadotropic hypogonadism treated with testosterone substitution | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012847-40 | Sponsor Protocol Number: Pergoveris_Cetrorelix_1 | Start Date*: 2009-11-11 | |||||||||||
Sponsor Name:NHS Lothian [...] | |||||||||||||
Full Title: A Randomised Study Comparing Two Different Regimens of Ovarian Stimulation Using Pergoveris and Cetrorelix for Controlled Ovarian Superovulation in Assisted Conception Treatment. | |||||||||||||
Medical condition: Subfertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000610-42 | Sponsor Protocol Number: VUmc_2021-5021 | Start Date*: 2021-05-03 |
Sponsor Name:Amsterdam UMC - location VUmc | ||
Full Title: Dynamic and test-retest whole body [18F]FES PET imaging in patients with metastatic ER+ breast cancer. | ||
Medical condition: Metastatic ER+ breast cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021195-28 | Sponsor Protocol Number: BAY 98-7161 / 14835 | Start Date*: 2011-02-25 |
Sponsor Name:Bayer HealthCare AG | ||
Full Title: Single-center, randomized, placebo-controlled, double-blind, parallel group study to evaluate whether a single-dose of either 20 mg piroxicam, 40 mg piroxicam or 80 mg piroxicam shows an effect on... | ||
Medical condition: Emergency Contraception | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002341-30 | Sponsor Protocol Number: 1705-VLC-030-JG | Start Date*: 2017-09-11 | |||||||||||
Sponsor Name:INSTITUTO VALENCIANO DE INFERTILIDAD (IVI) | |||||||||||||
Full Title: Usefulness of medroxyprogesterone acetate in the follicular phase for ovarian donors to prevent premature luteinization | |||||||||||||
Medical condition: prevent premature luteinitation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-009375-35 | Sponsor Protocol Number: rFSH+rhCG/rFSH+rLH | Start Date*: 2009-06-25 | |||||||||||
Sponsor Name:Regionshospital skive | |||||||||||||
Full Title: Den endokrine effekt af enten r-LH eller lav dosis r-hCG tilskud til r-FSH stimulering hos normogonadotrope kvinder som gennemgår IVF/ICSI behandling efter en lang GnRH agonist nedreguleringsprotocol | |||||||||||||
Medical condition: Fertilitetsbehandling. Sammenligne de endokrine effekter, specielt E2 niveau på hCG dagen hos normogonadatrope IVF/ICSI patienter, som får tilskud af LH aktivitet i form af enten rhCG eller rLH | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003981-42 | Sponsor Protocol Number: 2012.2708 | Start Date*: 2014-10-20 |
Sponsor Name:University Medical Center Groningen [...] | ||
Full Title: Estrogen receptor and androgen receptor imaging in metastatic breast cancer patients | ||
Medical condition: Estrogen receptor positive metastatic breast cancer patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-003106-29 | Sponsor Protocol Number: RANDOS | Start Date*: 2019-01-17 | |||||||||||
Sponsor Name:CHI Créteil | |||||||||||||
Full Title: Feasibility and efficacy of a new ovarian stimulation regimen with RANDom start, use of corifollitropin alpha and progestin protocol for Oocyte donorS | |||||||||||||
Medical condition: infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002679-34 | Sponsor Protocol Number: 1-2005 | Start Date*: 2005-11-02 |
Sponsor Name:The Fertility Clinic, Sygehus Viborg (Skive) | ||
Full Title: The effect of LH priming in early follicular phase on the endocrinological function of the ovary and pregnancy rate in GnRh downregulated women stimulated by exogen gonadotophins in IVF-treatment | ||
Medical condition: Infertility | ||
Disease: | ||
Population Age: | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004831-30 | Sponsor Protocol Number: UC-0101/1104 | Start Date*: 2012-09-21 | |||||||||||
Sponsor Name:UNICANCER | |||||||||||||
Full Title: Safety and efficacy of radiotherapy combined with a 6-month LH-RH agonist and abiraterone hormone therapy treatment in biochemically-relapsing prostate cancer following surgery. | |||||||||||||
Medical condition: Biochemically-relapsing prostate adenocarcinoma following radical prostatectomy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004493-42 | Sponsor Protocol Number: L-CP07-167 | Start Date*: 2014-12-03 | |||||||||||
Sponsor Name:Abbvie previously known as Abbott | |||||||||||||
Full Title: A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25 and 30 mg Formulations in Children with Central Precocious Puberty | |||||||||||||
Medical condition: Central Precocious Puberty | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
